Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
- PMID: 11460166
- DOI: 10.1038/35085588
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
Abstract
Genomic instability promotes tumorigenesis and can occur through various mechanisms, including defective segregation of chromosomes or inactivation of DNA mismatch repair. Although B-cell lymphomas are associated with chromosomal translocations that deregulate oncogene expression, a mechanism for genome-wide instability during lymphomagenesis has not been described. During B-cell development, the immunoglobulin variable (V) region genes are subject to somatic hypermutation in germinal-centre B cells. Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres. Mutations are distributed in the 5' untranslated or coding sequences, are independent of chromosomal translocations, and share features typical of V-region-associated somatic hypermutation. In contrast to mutations in V regions, however, these mutations are not detectable in normal germinal-centre B cells or in other germinal-centre-derived lymphomas, suggesting a DLCL-associated malfunction of somatic hypermutation. Intriguingly, the four hypermutable genes are susceptible to chromosomal translocations in the same region, consistent with a role for hypermutation in generating translocations by DNA double-strand breaks. By mutating multiple genes, and possibly by favouring chromosomal translocations, aberrant hypermutation may represent the major contributor to lymphomagenesis.
Similar articles
-
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.Blood. 2003 Sep 1;102(5):1833-41. doi: 10.1182/blood-2002-11-3606. Epub 2003 Apr 24. Blood. 2003. PMID: 12714522
-
Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.Blood. 2004 Mar 1;103(5):1869-75. doi: 10.1182/blood-2003-05-1465. Epub 2003 Oct 30. Blood. 2004. PMID: 14592832
-
Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.J Invest Dermatol. 2009 Feb;129(2):476-9. doi: 10.1038/jid.2008.243. Epub 2008 Aug 14. J Invest Dermatol. 2009. PMID: 18704108
-
The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.Pathol Biol (Paris). 2007 Feb;55(1):73-83. doi: 10.1016/j.patbio.2006.04.001. Epub 2006 Jul 3. Pathol Biol (Paris). 2007. PMID: 16815642 Review.
-
Mechanisms of chromosomal translocations in B cell lymphomas.Oncogene. 2001 Sep 10;20(40):5580-94. doi: 10.1038/sj.onc.1204640. Oncogene. 2001. PMID: 11607811 Review.
Cited by
-
Orientation Regulation of Class-switch Recombination in Human B Cells.J Immunol. 2024 Oct 15;213(8):1093-1104. doi: 10.4049/jimmunol.2300842. J Immunol. 2024. PMID: 39248600 Free PMC article.
-
Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma.PLoS One. 2012;7(7):e40332. doi: 10.1371/journal.pone.0040332. Epub 2012 Jul 12. PLoS One. 2012. PMID: 22808135 Free PMC article.
-
PIM1 gene cooperates with human BCL6 gene to promote the development of lymphomas.Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5735-9. doi: 10.1073/pnas.1201168109. Epub 2012 Mar 26. Proc Natl Acad Sci U S A. 2012. PMID: 22451912 Free PMC article.
-
Gene arrays in lymphoma: Where will they fit in?Curr Hematol Malig Rep. 2006 Jun;1(2):129-36. doi: 10.1007/s11899-006-0024-5. Curr Hematol Malig Rep. 2006. PMID: 20425343 Review.
-
The Immunology of DLBCL.Cancers (Basel). 2023 Jan 29;15(3):835. doi: 10.3390/cancers15030835. Cancers (Basel). 2023. PMID: 36765793 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases